Wally Smith, MD, Virginia Commonwealth University
Articles by Wally Smith, MD, Virginia Commonwealth University
Sickle Cell Disease: Unmet Needs and Future Directions in Care
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Nirmish Ramesh Shah, MD, Duke University,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center Concluding their discussion on sickle cell disease management, expert panelists share key unmet needs and hopes for the future.
Educating Patients on Gene Therapy in Sickle Cell Disease
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Nirmish Ramesh Shah, MD, Duke University,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center Shared insight on patient education surrounding gene therapy in sickle cell disease and common misconceptions about this approach.
Understanding the Risk-Benefit Ratio of Gene Therapy in SCD
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Nirmish Ramesh Shah, MD, Duke University,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center An overview of gene therapy in sickle cell disease with a focus on the risk-benefit ratio observed in clinical trials and practice.
Factors in Selecting Disease-Modifying Therapy in SCD
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center,Nirmish Ramesh Shah, MD, Duke University Panelists take a step back to consider when they might use certain disease-modifying therapy in the setting of sickle cell disease.
Sickle Cell Disease Management: Voxelotor Therapy
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Nirmish Ramesh Shah, MD, Duke University,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center Considerations for voxelotor’s unique mechanism of action and prospective use in patients with sickle cell disease.
Crizanlizumab Use in Sickle Cell Disease
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Nirmish Ramesh Shah, MD, Duke University,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center Panelists share their perspectives on the selection and use of crizanlizumab in certain patients with sickle cell disease.
Sickle Cell Disease Management: L-Glutamine Therapy
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Nirmish Ramesh Shah, MD, Duke University,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center Shared insight on L-glutamine therapy in sickle cell disease, with deference to observed efficacy and safety considerations.
Hydroxyurea Use in Sickle Cell Disease
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Nirmish Ramesh Shah, MD, Duke University,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center Expert perspectives on hydroxyurea as a staple therapy in the treatment armamentarium for sickle cell disease.
Treatment Goals and Guidelines in Sickle Cell Disease
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Nirmish Ramesh Shah, MD, Duke University,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center Focusing on disease-modifying therapeutics, expert panelists discuss foundational treatment goals and guidelines for sickle cell disease.
Patient Follow-up and Pain Management in Sickle Cell Disease
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Nirmish Ramesh Shah, MD, Duke University,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center Reflections on optimal approaches to patient follow-up, particularly regarding pain management and inherent risks in high-dose opioids.
Sickle Cell Disease: Applying Comprehensive Care to Patients
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Nirmish Ramesh Shah, MD, Duke University,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center A focused discussion on how comprehensive care is applied by multidisciplinary teams to improve the management of sickle cell disease.
Sickle Cell Disease: Overview of the Comprehensive Care Team
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Nirmish Ramesh Shah, MD, Duke University,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center A broad perspective on the value of multimodality care in the management of patients diagnosed with sickle cell disease.
Management of SCD: Educating Patients on Symptoms and Lifestyle Modification
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Nirmish Ramesh Shah, MD, Duke University,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center Wally Smith, MD, and Payal Desai, MD, spearhead a discussion on patient education surrounding sickle cell disease symptomology and lifestyle modifications.
Sickle Cell Disease and Newborn Screening
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Nirmish Ramesh Shah, MD, Duke University,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center Expert perspectives on the importance of newborn screening to impact mortality rates in sickle cell disease.
Sickle Cell Disease Global Prevalence
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Nirmish Ramesh Shah, MD, Duke University,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center Expert panelists reflect on the global prevalence of sickle cell disease, as well as general disease awareness.
Progression of SCD and Management Throughout a Patient’s Life
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Nirmish Ramesh Shah, MD, Duke University,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center Shared insight on how a patient’s life may progress following a diagnosis of sickle cell disease, along with considerations for pediatric versus adult management.
Overview of Sickle Cell Disease: Pathophysiology and Clinical Burden
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Payal Desai, MD, Formerly OSU Comprehensive Cancer Center,Nirmish Ramesh Shah, MD, Duke University An overview on the pathophysiology of sickle cell disease and expert perspectives on the clinical (and psychosocial) burden it presents.
Physician Advice for Patients With SCD
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Jamaal Bailey,Sherry Bailey ,Cassandra Trimnell, Patient Advocate, Sickle Cell 101 Wally Smith, MD, shares his take-home points for patients with sickle cell disease and urges to get tested for sickle cell trait.
Advice for Patients With SCD and Their Caregivers
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Jamaal Bailey,Sherry Bailey ,Cassandra Trimnell, Patient Advocate, Sickle Cell 101 A patient, patient advocate, and caregiver provide advice to those in the sickle cell disease community based on their own experiences.
Educating Patients With SCD About the Associated Pain and Anemia
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Jamaal Bailey,Sherry Bailey ,Cassandra Trimnell, Patient Advocate, Sickle Cell 101 A patient with SCD describes how connecting with others in the sickle cell community via social media has brought him comfort.
Patient Advocacy and Education in SCD
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Jamaal Bailey,Sherry Bailey ,Cassandra Trimnell, Patient Advocate, Sickle Cell 101 Patient advocate, Cassandra Trimnell, shares her perspective on becoming an advocate for the sickle cell disease community and continuously learning about it.
Advocacy as Part of Sickle Cell Disease Management
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Jamaal Bailey,Sherry Bailey ,Cassandra Trimnell, Patient Advocate, Sickle Cell 101 A patient advocate for sickle cell disease explains how advocacy helps her to manage her disease and why she chooses to be an advocate and educate the sickle cell community.
Patient Experience With Treatments for SCD
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Jamaal Bailey,Sherry Bailey ,Cassandra Trimnell, Patient Advocate, Sickle Cell 101 A patient with SCD and his caregiver share their experiences with the treatment options he received since the diagnosis.
Patient Factors Associated With the Choice of SCD Therapy
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Jamaal Bailey,Sherry Bailey ,Cassandra Trimnell, Patient Advocate, Sickle Cell 101 Wally Smith, MD, discusses the mechanisms of actions of various therapies for SCD and the patient factors associated with the choice of therapy.
Evolution of Therapies in Sickle Cell Disease
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Jamaal Bailey,Sherry Bailey ,Cassandra Trimnell, Patient Advocate, Sickle Cell 101 Wally Smith, MD, reviews the goals of treatment and discusses current disease-modifying therapies for SCD.
Building Relationships in the SCD Community
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Jamaal Bailey,Sherry Bailey ,Cassandra Trimnell, Patient Advocate, Sickle Cell 101 A patient advocate speaks about connecting with sickle cell disease communities to improve mental health and create disease awareness.
The Mental Health Journey With Sickle Cell Disease
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Jamaal Bailey,Sherry Bailey ,Cassandra Trimnell, Patient Advocate, Sickle Cell 101 A patient with SCD and his mother discuss their mental health journey with sickle cell disease and resources that helped them.
Mental Health and Sickle Cell Disease
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Jamaal Bailey,Sherry Bailey ,Cassandra Trimnell, Patient Advocate, Sickle Cell 101 A discussion on the importance of mental health awareness and utilization of mental health resources in sickle cell disease, given the statistics of the disorder.
Pain Management With Sickle Cell Disease
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Jamaal Bailey,Sherry Bailey ,Cassandra Trimnell, Patient Advocate, Sickle Cell 101 Cassandra Trimnell, a patient advocate, narrates her experience in dealing with the physical and emotional pain of sickle cell disease and finding the beauty in living with the disorder.
A Young Mother’s Journey With Sickle Cell Disease
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Wally Smith, MD, Virginia Commonwealth University ,Jamaal Bailey,Sherry Bailey ,Cassandra Trimnell, Patient Advocate, Sickle Cell 101 Patient advocate, Cassandra Trimnell, talks about her experience of being a mother with sickle cell disease.
Patient Experience With Treatments for SCD
The Mental Health Journey With Sickle Cell Disease
Advice for Patients With SCD and Their Caregivers
Patient Advocacy and Education in SCD
Patient Factors Associated With the Choice of SCD Therapy
Advocacy as Part of Sickle Cell Disease Management